| Breakdown | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|
Income Statement | |||||
| Total Revenue | 22.35B | 8.83B | 9.94B | 11.00B | 10.55B |
| Gross Profit | 8.37B | 8.83B | 9.94B | 13.23B | 12.94B |
| EBITDA | 4.03B | 4.53B | 5.59B | 6.71B | 6.38B |
| Net Income | 3.75B | 4.62B | 5.16B | 5.93B | 5.59B |
Balance Sheet | |||||
| Total Assets | 796.53B | 745.90B | 708.85B | 657.69B | 593.36B |
| Cash, Cash Equivalents and Short-Term Investments | 37.34B | 53.07B | 21.97B | 54.00B | 47.73B |
| Total Debt | 171.37B | 84.04B | 12.12B | 64.51B | 68.32B |
| Total Liabilities | 733.48B | 683.44B | 651.37B | 603.87B | 543.38B |
| Stockholders Equity | 60.32B | 59.55B | 54.65B | 51.13B | 47.38B |
Cash Flow | |||||
| Free Cash Flow | -22.02B | -47.22B | -12.29B | 28.94B | -16.40B |
| Operating Cash Flow | -21.66B | -46.97B | -12.09B | 29.28B | -16.02B |
| Investing Cash Flow | -41.76B | 22.22M | -22.80B | -20.03B | -8.69B |
| Financing Cash Flow | 61.61B | 40.57B | 31.59B | 37.64B | 20.66B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
68 Neutral | HK$16.15B | 7.00 | 5.34% | 3.57% | 6.65% | 16.74% | |
68 Neutral | $18.00B | 11.42 | 9.92% | 3.81% | 9.73% | 1.22% | |
67 Neutral | HK$31.31B | 3.97 | 12.57% | 4.45% | 4.33% | 17.13% | |
64 Neutral | HK$16.29B | 4.21 | 3.63% | 1.89% | -5.02% | -3.28% | |
57 Neutral | HK$15.28B | 2.83 | 4.11% | ― | -5.76% | 18.15% | |
56 Neutral | HK$23.42B | 5.83 | 6.51% | 7.99% | -7.29% | -14.37% |